We are no longer accepting applications for the 2020 ASTRO-PCF Career Development Award to End Prostate Cancer.
What is the goal of the ASTRO-PCF Career Development Award?
To advance the field of radiation oncology in novel ways through support of talented early career scientists performing radiation oncology-related research. The aim of the CDA is to support the next generation of researchers and to significantly improve outcomes and quality of life for prostate cancer patients.
The award will provide up to $75,000 per year for three years to be combined with matching funds or in kind contribution from the applicant’s institution. Neither ASTRO nor PCF will pay indirect costs as part of this award. One award will be funded. Research must be focused on understanding or treatment of prostate cancer and include use or impact of radiation treatment.
Am I eligible?
You are eligible if:
- You are an investigator employed by a recognized U.S. research institution (PhD, MD or MD/PhD) with no more than five years in a faculty appointment at the time of application, and an ASTRO member in good standing.
- Investigators must designate a mentor, preferably one at the same institution, who will provide guidance and support. Mentors should be senior investigators with a minimum of R01 or equivalent level funding and provide a letter of support detailing their oversight and support.
- Successful applicants must attend at least one ASTRO Annual Meeting and the PCF Research Meeting and present the findings of this research study at both meetings.
- Other eligibility requirements as listed in the full RFA.
Your institutions's responsibilities:
- The department or institution must provide matching funds or an in-kind contribution to further support the PI and research effort. In-kind contributions can include protected time for research, access to dedicated space, core research facilities, or similar types of contributions.
- A written letter from the institution detailing a commitment to the development of the applicant as a productive, independent investigator, as well as intent for 50 percent of the recipient’s full time professional effort to be devoted to research, will be required.
- The institution will be required to provide sufficient additional funds to supplement salaries or supplies as needed for the research.
- Other responsibilities as listed in the full RFA.
What are the terms of the award?
One junior faculty is selected annually for this award, which provides $75,000 each year for three years.
At least 50% of the recipient’s full-time professional effort must be devoted to research. The remainder may be devoted to clinical, teaching or other pursuits.
How do I apply?
The applications will be accepted through ProposalCentral's online submission service. Paper applications are not accepted. For more details please see full RFA.
When is the application deadline?
Applications were due on February 15, 2020.
When does the award begin?
The start date for 2020 award is anticipated as July 1, 2020, and will run through June 30, 2023. For any questions please email the Scientific Affairs Department.
What if I don't complete my work within three years?
ASTRO allows for no-cost extensions on a case-by-case basis. Requests for no-cost extensions must be submitted to ASTRO's Scientific Affairs division.